These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36583484)

  • 1. MiR-101-3p targets KPNA2 to inhibit the progression of lung squamous cell carcinoma cell lines.
    Dong L; Jiang H; Qiu T; Xu Y; Chen E; Huang A; Ying K
    Histol Histopathol; 2023 Oct; 38(10):1169-1178. PubMed ID: 36583484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2.
    Wang H; Xiao R; Yang B
    Technol Cancer Res Treat; 2021; 20():15330338211055948. PubMed ID: 34816790
    [No Abstract]   [Full Text] [Related]  

  • 3. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
    Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.
    Hou Y; Li L; Ju Y; Lu Y; Chang L; Xiang X
    J Cell Biochem; 2017 Oct; 118(10):3142-3149. PubMed ID: 27966775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.
    Zhang Q; Wang Y
    Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
    Li H; Zhao Q; Tang Z
    Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
    Lu Y
    Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
    Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
    BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2.
    Ma J; Miao H; Zhang H; Ren J; Qu S; Da J; Xu F; Zhao H
    Diagn Pathol; 2021 May; 16(1):46. PubMed ID: 34022918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREB1 regulates KPNA2 by inhibiting mir-495-3p transcription to control melanoma progression : The role of the CREB1/miR-495-3p/KPNA2 axis in melanoma progression.
    Geng X; Qiu X; Gao J; Gong Z; Zhou X; Liu C; Luo H
    BMC Mol Cell Biol; 2022 Dec; 23(1):57. PubMed ID: 36522613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ_0079593 promotes glioma development through regulating KPNA2 expression by sponging miR-499a-5p.
    Yang Z; Li C; Fan XY; Liu LJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(3):1288-1301. PubMed ID: 32096160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
    Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
    Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
    Lu P; Jiang Y; Xia Z
    Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
    Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
    J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.